tiprankstipranks
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
Germany Market
52U
Hyloris Pharmaceuticals SA
RESEARCH TOOLSreports
Want to see DE:52U full AI Analyst Report?

Hyloris Pharmaceuticals SA (52U) Income Statement

7 Followers

Hyloris Pharmaceuticals SA Income Statement

Last quarter (Q2 2025), Hyloris Pharmaceuticals SA's total revenue was €1.67M, a decrease of -28.04% from the same quarter last year. In Q2, Hyloris Pharmaceuticals SA's net income was €-1.78M. See Hyloris Pharmaceuticals SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 7.21M€ 10.04M€ 2.09M€ 2.95M€ 3.10M
Gross Profit
€ 5.91M€ 9.81M€ 1.99M€ 2.86M€ 2.99M
Operating Expenses
€ 15.24M€ 16.95M€ 17.99M€ 13.37M€ 13.34M
Depreciation and Amortization
€ 919.00K€ 1.23M€ 348.00K€ 196.00K€ 114.00K
EBITDA
€ -8.42M€ -4.85M€ -14.98M€ -11.43M€ -10.78M
Operating Income
€ -9.34M€ -7.13M€ -15.99M€ -11.64M€ -4.94M
Other Income/Expenses
€ 2.63M€ 788.00K€ 613.00K€ -263.00K€ -741.00K
Pretax Income
€ -6.71M€ -6.34M€ -15.38M€ -11.90M€ -11.28M
Net Income
€ -6.33M€ -6.34M€ -15.38M€ -11.91M€ -11.58M
Per Share Metrics
Basic EPS
€ -0.23€ -0.22€ -0.55€ -0.44€ -0.45
Diluted EPS
€ -0.23€ -0.22€ -0.55€ -0.44€ -0.45
Weighted Average Shares Outstanding
 27.54M 29.04M 28.00M 27.20M 25.83M
Weighted Average Shares Outstanding (Diluted)
 27.54M 29.04M 28.00M 27.20M 25.83M
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History